Quellen:
Mullens, Wilfried et al. “Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.” The New England journal of medicine, 10.1056/NEJMoa2203094. 27 Aug. 2022, doi:10.1056/NEJMoa2203094
https://pubmed.ncbi.nlm.nih.gov/36027559/
Lyon, Alexander R et al. “2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).” European heart journal, ehac244. 26 Aug. 2022, doi:10.1093/eurheartj/ehac244
https://pubmed.ncbi.nlm.nih.gov/36017568/
Solomon, Scott D et al. “Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.” The New England journal of medicine, 10.1056/NEJMoa2206286. 27 Aug. 2022, doi:10.1056/NEJMoa2206286
https://pubmed.ncbi.nlm.nih.gov/36027570/